New guidelines recommend that, for metastatic CRC patients, the minimum gene regions to test are exon 2, 3, and 4 of KRAS and NRAS and exon 15 of BRAF. Given these recommendations, methods that test the status of multiple genes at once are required. The gene discussed is KRAS; the disease is colorectal carcinoma.